Form 8-K - Current report:
SEC Accession No. 0001193125-24-196974
Filing Date
2024-08-08
Accepted
2024-08-08 16:13:30
Documents
15
Period of Report
2024-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d831251d8k.htm   iXBRL 8-K 24390
2 EX-99.1 d831251dex991.htm EX-99.1 179562
6 GRAPHIC g831251dsp05a.jpg GRAPHIC 3828
  Complete submission text file 0001193125-24-196974.txt   353824

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA btmd-20240808.xsd EX-101.SCH 2832
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE btmd-20240808_lab.xml EX-101.LAB 17978
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btmd-20240808_pre.xml EX-101.PRE 11246
17 EXTRACTED XBRL INSTANCE DOCUMENT d831251d8k_htm.xml XML 3639
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

IRS No.: 851791125 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40128 | Film No.: 241188485
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)